MCID: HRP004
MIFTS: 56

Herpes Zoster malady

Categories: Skin diseases, Infectious diseases

Aliases & Classifications for Herpes Zoster

About this section

Aliases & Descriptions for Herpes Zoster:

Name: Herpes Zoster 11 49 50 2 39 13
Shingles 11 49 38 2 13
 
Herpes Zoster Disease 68
Herpes Zona 11

Classifications:



External Ids:

Disease Ontology11 DOID:8536
ICD1030 B02, B02.9
ICD9CM32 053
MeSH39 D006562
NCIt45 C71079

Summaries for Herpes Zoster

About this section
MedlinePlus:38 Shingles is a disease caused by the varicella-zoster virus - the same virus that causes chickenpox. after you have chickenpox, the virus stays in your body. it may not cause problems for many years. as you get older, the virus may reappear as shingles. although it is most common in people over age 50, anyone who has had chickenpox is at risk. you can't catch shingles from someone who has it. however, if you have a shingles rash, you can pass the virus to someone who has never had chickenpox. this would usually be a child, who could get chickenpox instead of shingles. the virus spreads through direct contact with the rash, and cannot spread through the air. early signs of shingles include burning or shooting pain and tingling or itching, usually on one side of the body or face. the pain can be mild to severe. rashes or blisters appear anywhere from one to 14 days later. if shingles appears on your face, it may affect your vision or hearing. the pain of shingles may last for weeks, months, or even years after the blisters have healed. there is no cure for shingles. early treatment with medicines that fight the virus may help. these medicines may also help prevent lingering pain. a vaccine may prevent shingles or lessen its effects. the vaccine is recommended for people 60 or over. in some cases doctors may give it to people ages 50 to 59. nih: national institute of allergy and infectious diseases

MalaCards based summary: Herpes Zoster, also known as shingles, is related to facial paralysis and pulmonary tuberculosis, and has symptoms including angina pectoris, back pain and exanthema. An important gene associated with Herpes Zoster is DPYD (Dihydropyrimidine Dehydrogenase), and among its related pathways are Inflammatory Response Pathway and Calcineurin-regulated NFAT-dependent transcription in lymphocytes. The drugs valacyclovir and capsicum oleoresin have been mentioned in the context of this disorder. Affiliated tissues include nerve fiber, skin and eye.

Disease Ontology:11 A viral infectious disease that results in infection located in nerve fiber, has material basis in Human herpesvirus 3, which reactivates after appearing as chickenpox in childhood. The virus is transmitted by direct contact with the rash, which can develop into chickenpox in newly-infected individuals. The infection has symptom rash which is followed by blisters, has symptom headache, has symptom fever, has symptom malaise, has symptom itching, has symptom burning pain, and has symptom paresthesia.

CDC:2 Almost 1 out of every 3 people in the United States will develop shingles, also known as zoster or herpes zoster, in their lifetime. There are an estimated 1 million cases of shingles each year in this country. Anyone who has recovered from chickenpox may develop shingles; even children can get shingles. However the risk of shingles increases as you get older. About half of all cases occur in men and women 60 years old or older...

NINDS:49 Shingles (herpes zoster) is an outbreak of rash or blisters on the skin that is caused by the same virus that causes chickenpox — the varicella-zoster virus. The first sign of shingles is often burning or tingling pain (which can be severe), or sometimes numbness or itch,generally on one side of the body. After several days or a week, a rash of fluid-filled blisters, similar to chickenpox, appears in one area on one side of the body. Shingles pain can be mild or intense.  Some people have mostly itching; some feel pain from the gentlest touch or breeze.  The most common location for shingles is a band, called a dermatome, spanning one side of the trunk around the waistline. Anyone who has had chickenpox is at risk for shingles.  Scientists think that some of the virus particles from the original exposure to the varicella-zoster virus,leave the skin blisters and move into the nervous system.  When the varicella-zoster virus reactivates, the virus moves back down the long nerve fibers that extend from the sensory cell bodies to the skin.  The viruses multiply, the tell-tale rash erupts, and the person now has shingles.

Wikipedia:71 Shingles, also known as herpes zoster, is a viral disease characterized by a painful skin rash with... more...

Related Diseases for Herpes Zoster

About this section

Diseases related to Herpes Zoster via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50)    (show all 336)
idRelated DiseaseScoreTop Affiliating Genes
1facial paralysis29.5CD40LG, IL10
2pulmonary tuberculosis29.4CD40LG, IFNG, IL10
3anaplastic large cell lymphoma29.3IFNG, IL2, TMPO
4chorioretinitis29.3CD40LG, FCGR3A, IFNG, IL10
5hepatitis29.3HLA-A, IFNG, IL10, IL2
6myiasis29.3CD40LG, IFNG, IL10, IL2
7tuberculosis29.2CD40LG, CD8A, IL10, IL2
8acute dacryoadenitis29.1CD40LG, CD8A, IL2
9geniculate herpes zoster12.5
10herpes zoster ophthalmicus12.5
11postherpetic neuralgia11.6
12asymptomatic neurosyphilis10.3IFNG, IL10
13autoimmune progesterone dermatitis10.2IFNG, TRPV1
14maturity-onset diabetes of the young10.2CD40LG, IL10
15renal agenesis meningomyelocele mullerian defect10.2IFNA2, IL2
16caplan's syndrome10.2IFNG, IL2
17autosomal dominant deafness-onychodystrophy syndrome10.2IFNG, IL2
18neurotic disorder10.2FCGR3A, IFNG, IL10
19diabetic angiopathy10.2CD40LG, IL10
20tungiasis10.2IFNG, IL10
21chondrodysplasia punctata, tibia-metacarpal type10.2CD40LG, IFNA2
22esophageal candidiasis10.2IFNA2, IFNG, IL10
23uterine ligament clear cell adenocarcinoma10.1IFNG, IL10, TRPV1
24lupus erythematosus10.1
25severe combined immunodeficiency, t cell-negative, b-cell/natural killer-cell positive10.1IFNG, IL10, IL2
26plantar wart10.1IFNG, IL10, IL2
27cyclosporiasis10.1IFNG, IL10, IL2
28chronic thromboembolic pulmonary hypertension10.1IFNG, IL10, IL2
29mental retardation, autosomal dominant 1910.1CD40LG, IFNA2
30acute myeloid leukemia with recurrent genetic anomaly10.1IFNG, IL10, IL2
31microcephaly10.1IFNG, IL10, IL2
32israeli tick typhus10.1CD40LG, IFNG
33abnormal retinal correspondence10.1IFNG, IL10, IL2
34rheumatoid arthritis10.1
35arthritis10.1
36causalgia10.1IFNG, IL10, IL2
37mansonelliasis10.1IFNG, IL10, IL2
38osteoarthritis10.1DPYD, FCGR3A, IFNA2
39dengue hemorrhagic fever10.1IFNG, IL10, IL2
40facial nerve neoplasm10.1CD40LG, COL17A1
41liver inflammatory pseudotumor10.1IFNG, IL10, IL2
42blue toe syndrome10.1IFNG, IL10, IL2
43hemiplegia10.1
44retinitis10.1
45prostatic urethral cancer10.1IFNG, IL10, IL2
46pigmentation disease10.1IFNG, IL10, IL2
47type 2 papillary adenoma of the kidney10.1CD40LG, FCGR3A, IL10
48periarthritis10.1IFNG, IL10, IL2
49spastic ataxia 7, autosomal dominant10.1CD40LG, COL17A1
50chickenpox10.1

Graphical network of the top 20 diseases related to Herpes Zoster:



Diseases related to herpes zoster

Symptoms & Phenotypes for Herpes Zoster

About this section

Symptoms:

 11 (show all 7)
  • rash which is followed by blisters
  • headache
  • fever
  • malaise
  • itching
  • burning pain
  • paresthesia

UMLS symptoms related to Herpes Zoster:


angina pectoris, back pain, exanthema, fever, headache, pain, pruritus, sciatica, seizures, syncope, tremor, chronic pain, vertigo/dizziness, equilibration disorder, sleeplessness

Drugs & Therapeutics for Herpes Zoster

About this section

Drugs for Herpes Zoster (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50)    (show all 371)
idNameStatusPhaseClinical TrialsCas NumberPubChem Id
1
Etoricoxibapproved, investigationalPhase 493202409-33-4123619
Synonyms:
202409-33-4
5-Chloro-3-(4-methanesulfonyl-phenyl)-6'-methyl-[2,3']bipyridinyl
5-Chloro-6'-methyl-3-(p-(methylsulfonyl)phenyl)-2,3'-bipyridine
5-chloro-2-(6-Methylpyridin-3-yl)-3-(4-(methylsulfonyl)phenyl)pyridine
5-chloro-2-(6-methylpyridin-3-yl)-3-(4-methylsulfonylphenyl)pyridine
5-chloro-6'-Methyl-3-(P-(methylsulfonyl)phenyl)-2,3'-bipyridine
5-chloro-6'-methyl-3-[4-(methylsulfonyl)phenyl]-2,3'-bipyridine
5CH
AC1L3WZM
Algix
Arcoxia
C11718
C422649
CHEBI:106706
CHEBI:6339
CHEMBL416146
CID123619
D03710
DB01628
DB07166
ETORICOXIB
 
Etoricoxib
Etoricoxib (USAN/INN)
Etoricoxib [USAN:INN:BAN]
Etoricoxibe
Etoricoxibum
FT-0082494
HMS2090A05
L-791456
L001141
L791456
LS-181802
MK 0663
MK 663
MK-0663
MK-663
Merck Sharp & Dohme brand of etoricoxib
MolPort-003-847-339
NCGC00164578-01
Nucoxia
Tauxib
UNII-WRX4NFY03R
ZINC00579472
2
CapsaicinapprovedPhase 4, Phase 3, Phase 2176404-86-41548943
Synonyms:
(6E)-N-(4-hydroxy-3-methoxybenzyl)-8-methylnon-6-enamide
(6E)-N-{[4-hydroxy-3-(methyloxy)phenyl]methyl}-8-methylnon-6-enamide
(E)-8-Methyl-N-vanillyl-6-nonenamide
(E)-8-Methyl-N-vanillyl-6-nonenamide(8cl)
(E)-Capsaicin
(E)-N-((4-Hydroxy-3-methoxyphenyl)-methyl)-8-methyl-6-nonenamide
(E)-N-[(4-hydroxy-3-methoxyphenyl)methyl]-8-methylnon-6-enamide
(E)8-methyl-N-vanillyl-6-Nonenamide
12084_FLUKA
21748_FLUKA
21748_SIGMA
21750_FLUKA
21750_SIGMA
360376_ALDRICH
360376_SIGMA
404-86-4
6-Nonenamide, (E)-N-((4-hydroxy-3-methoxy-phenyl)methyl)-8-methyl
6-Nonenamide, 8-methyl-N-vanillyl-, (E)- (8CI)
8 Methyl N Vanillyl 6 Nonenamide
8-Methyl-N-Vanillyl-6-Nonenamide
8-Methyl-N-vanillyl-trans-6-nonenamide
912457-62-6
AC1LU7K3
AC1Q46B3
Alacan Brand of Capsaicin
Antiphlogistine Rub A-535 Capsaicin
Axsain
BPBio1_001053
BRD-K37056290-001-01-1
BRD-K50590187-001-06-6
BRN 2816484
BSPBio_000957
BSPBio_001548
BSPBio_002917
Bio-0615
C-1700
C06866
C18H27NO3
CAPSAICIN (2444-46-4 NONIVAMIDE (SYNTHETIC CAPSAICIN))
CAPSAICINE
CCRIS 1588
CHEBI:3374
CHEMBL294199
CID1548943
Capsaicin
Capsaicin (JAN/USP)
Capsaicin (Natural)
Capsaicin (in oleoresin of capsicum)
Capsaicin (jan/usp)
Capsaicin Patch
Capsaicin [USAN]
Capsaicin [in oleoresin of capsicum]
Capsaicin [usan]
Capsicum Farmaya
Capsidol
Capsin
Capzasin
Carter Horner Brand of Capsaicin
Caswell No. 158
Centrum Brand of Capsaicin
D002211
D00250
E-CAPSAICIN
E-Capsaicin
EINECS 206-969-8
EPA Pesticide Chemical Code 070701
Elan Brand of Capsaicin
FEMA No. 3404
FT-0082538
Flemming Brand of Capsaicin
Gelcen
HMS1361N10
HMS1570P19
HMS1791N10
HMS1921H11
HMS1989N10
 
HMS2089N11
HMS2092D21
HMS501B16
HSDB 954
I01-2469
IDI1_000354
IDI1_034018
Isodecenoate
Isodecenoic acid
Isodecenoic acid vanillylamide
Katrum
LS-2138
Link Brand of Capsaicin
M1149
M2028_SIGMA
MEGxp0_001448
MLS002154049
MR3H3
Medicis Brand of Capsaicin
MolPort-001-742-263
N-(4-Hydroxy-3-methoxybenzyl)-8-methylnon-trans-6-enamide
N-(4-hydroxy-3-methoxybenzyl)-8-methylnon-6-enamide
N-[(4-Hydroxy-3-methoxyphenyl)methyl]-8-methyl-6-nonenamide
N-[(4-hydroxy-3-methoxy-phenyl)methyl]nonanamide
NCGC00090853-01
NCGC00090853-02
NCGC00090853-03
NCGC00090853-04
NCGC00090853-06
NCGC00090853-07
NCGC00090853-08
NCGC00090853-09
NCI-C56564
NGX 4010
NGX-1998
NGX-3781
NGX-4010
NGX-7325
NGX4010
NSC 56353
NSC56353
Prestwick2_000879
Prestwick3_000879
Prestwick_204
Qutenza
S1990_Selleck
SDCCGMLS-0066678.P001
SMP2_000337
SMR000718774
SPECTRUM1501128
Smaller Brand of Capsaicin
Spectrum5_000538
Styptysat
TL8002946
TQ-1018
Thompson Brand of Capsaicin
Transacin
UNII-S07O44R1ZM
UPCMLD-DP092
UPCMLD-DP092:001
UPCMLD-DP092:002
Vinas Brand of Capsaicin
ZINC01530575
ZOSTRIX (TN)
Zacin
Zostrix
Zostrix (TN)
Zostrix HP
[(E)-N-(4-Hydroxy-3-methoxyphenyl)methyl]-8-methyl-6-nonenamide
depletes Substance P
epsilon-Capsaicin
n-(4-hydroxy-3-methoxybenzyl)-8-methyl-6-nonenamide
nchembio.146-comp1
nchembio862-comp2
neurotoxic
trans-8-Methyl-N-vanillyl-6-nonenamide
trans-Capsaicin
3
Prednisoloneapproved, vet_approvedPhase 4, Phase 2119350-24-85755
Synonyms:
(11beta)-11,17,21-Trihydroxypregna-1,4-diene-3,20-dione
.DELTA.1-Cortisol
.DELTA.1-Dehydrocortisol
.DELTA.1-Dehydrohydrocortisone
.DELTA.1-Hydrocortisone
.delta.-Cortef
.delta.-Stab
1,2-Dehydrohydrocortisone
1,4-Pregnadiene-11beta,17alpha,21-triol-3,20-dione
1,4-Pregnadiene-3,20-dione-11beta,17alpha,21-triol
1-Dehydrocortisol
1-Dehydrohydrocortisone
3,20-dioxo-11beta,17alpha,21-Trihydroxy-1,4-pregnadiene
46656_FLUKA
46656_RIEDEL
50-24-8
58201-11-9
8056-11-9
AC-1773
AC1L1L2E
Ak-Pred
Ak-Tate
Alphadrol
Articulose-50
BPBio1_000164
BRD-K98039984-001-03-0
BRN 1354103
BSPBio_000148
Bio-0666
Bubbli-Pred
C07369
CCRIS 980
CHEBI:8378
CHEMBL131
CID5755
CO-Hydeltra
CPD000718761
Co-Hydeltra
Codelcortone
Cordrol
Cortalone
Cotogesic
Cotolone
D00472
D011239
DB00860
Decaprednil
Decortin H
Delcortol
Delta F
Delta(1)-dehydrohydrocortisone
Delta-Cortef
Delta-Cortef (TN)
Delta-Ef-Cortelan
Delta-Stab
Delta-stab
Deltacortenol
Deltacortril
Deltacortril Enteric
Deltahydrocortisone
Deltasolone
Deltisilone
Depo-Medrol
Derpo PD
Derpo Pd
Dexa-Cortidelt Hostacortin H
Dexa-Cortidelt hostacortin H
Di Adreson F
Di-Adreson F
Di-Adreson-F
Di-adreson F
DiAdresonF
Dicortol
Donisolone
Dydeltrone
EINECS 200-021-7
Eazolin D
Econopred
Econopred Plus
Erbacort
Erbasona
Estilsona
Fernisolone
Fernisolone P
Fernisolone-P
Flamasone
HMS1568H10
HMS2090J05
HSDB 3385
Hostacortin H
Hydeltra
Hydeltra-Tba
Hydeltrasol
Hydeltrone
Hydrodeltalone
Hydrodeltisone
Hydroretrocortin
Hydroretrocortine
I-Pred
Inflamase Forte
Inflamase Mild
K 1557
Key-Pred
Klismacort
LMST02030179
LS-7669
Lentosone
Lite Pred
M-Predrol
 
MLS001304083
MLS002154250
MLS002207037
Medrol
Medrol Acetate
Metacortandralone
Methylprednisolone Acetate
Meti-Derm
Meticortelone
Metreton
MolPort-002-507-147
NCGC00179649-01
NSC 9120
NSC9120
NSC9900
Neo-Delta-Cortef
Nisolone
Nor-Pred T.B.A.
Ocu-Pred
Ocu-Pred Forte
Ophtho-Tate
Orapred
P0152_SIGMA
P0637
P6004_SIGMA
PRDL
PRED-G
Panafcortelone
Paracortol
Paracotol
Pediapred
Poly-Pred
Precortalon
Precortancyl
Precortilon
Precortisyl
Pred Forte
Pred Mild
Predair
Predair A
Predair Forte
Predalone 50
Predalone T.B.A.
Predate
Predate Tba
Predate-50
Predcor-25
Predcor-50
Predcor-Tba
Predisolone Sodium Phosphate
Predne-Dome
Prednelan
Predni-Dome
Prednicen
Predniliderm
Predniretard
Prednis
Prednisolona
Prednisolona [INN-Spanish]
Prednisolone (JP15/USP/INN)
Prednisolone (anhydrous)
Prednisolone Acetate
Prednisolone Sodium Phosphate
Prednisolone Tebutate
Prednisolone [INN:BAN:JAN]
Prednisolonum
Prednisolonum [INN-Latin]
Predonin
Predonine
Prelone
Prenolone
Prestwick0_000274
Prestwick1_000274
Prestwick2_000274
Prestwick3_000274
Prestwick_404
Rolisone
S1737_Selleck
SAM002264639
SMR000718761
SPBio_002367
Scherisolon
Solone
Steran
Sterane
Sterolone
Supercortisol
UNII-9PHQ9Y1OLM
Ulacort
Ultra Pred
Ultracorten H
Ultracortene H
Ultracortene-H
Ultracortene-Hydrogen
Ultracortene-hydrogen
ZINC03833821
component of Ataraxoid
component of K-Predne-Dome
delta(1)-Cortisol
delta(1)-Dehydrocortisol
delta(1)-Dehydrohydrocortisone
delta(1)-Hydrocortisone
delta(sup 1)-Cortisol
delta(sup 1)-Dehydrocortisol
delta(sup 1)-Dehydrohydrocortisone
delta(sup 1)-Hydrocortisone
delta-dehydrocortisol
delta-dehydrohydrocortisone
delta-hydrocortisone
prednisolone
4
FoscarnetapprovedPhase 43363585-09-1, 4428-95-93415
Synonyms:
1nki
34156-56-4
4428-95-9
4428-95-9 (Parent)
63585-09-1
63585-09-1 (tri-hydrochloride salt)
79510_FLUKA
A 29622
A-29622
AC-2085
AC1L1FVT
AC1L2C37
AC1L5400
AC1NB82R
AC1Q1UNV
AR-1L5079
Ambap63585-09-1
BSPBio_003067
C06456
CHEBI:127780
CHEBI:141644
CHEBI:60269
CHEMBL666
CHEMBL754
CID169569
CID3415
CID44561
Carboxyphosphonic acid
D00579
D02267
DB00529
DRG-0017
Dihydroxyphosphinecarboxylic acid oxide
Dihydroxyphosphinecarboxylic acid oxide and MSL, neutralizing monoclonal antibody
Dihydroxyphosphinecarboxylic acid oxide trisodium salt
Dihydroxyphosphinecarboxylic acid oxide trisodium salt hexahydrate
DivK1c_000915
EHB 776
EHB-776
FOSCARNET SODIUM
Formic acid, phosphono-, trisodium salt, hexahydrate
Forscarnet sodium
Foscarmet
Foscarnet & IFN-.ALPHA.
Foscarnet sodico
Foscarnet sodico [Spanish]
Foscarnet sodique
Foscarnet sodique [French]
Foscarnet sodique [INN-French]
Foscarnet sodium (USAN/INN)
Foscarnet sodium [USAN:INN:BAN]
Foscarnet sodium hydrate
Foscarnet sodium hydrate (JAN)
Foscarneto sodico
Foscarneto sodico [INN-Spanish]
Foscarnetum natricum
Foscarnetum natricum [INN-Latin]
Foscarnetum natricum [Latin]
Foscavir
Foscavir (TN)
HMS1921D18
HMS2092N15
HMS502N17
 
HS-0008
IDI1_000915
KBio1_000915
KBio2_001839
KBio2_004407
KBio2_006975
KBio3_002567
KBioGR_001419
KBioSS_001839
LS-105952
LS-105953
LS-183979
LS-187063
LS-187793
MSL & PFA
MolPort-003-665-560
MolPort-003-895-968
NCGC00094941-01
NCGC00094941-02
NChemBio.2007.9-comp7
NINDS_000915
NSC313410
P6801_ALDRICH
P6801_SIGMA
PFA & rIFN.alpha.A
Phgosphonocarboxylic acid
Phosphinecarboxylic acid, dihydroxy-, oxide
Phosphinecarboxylic acid, dihydroxy-, oxide, trisodium salt
Phosphinecarboxylic acid, dihydroxy-, oxide, trisodium salt, hexahydrate
Phosphonoformate
Phosphonoformate(trisodium) & Recombinant Alpha-A Interferon
Phosphonoformic acid
Phosphonoformic acid & IFN-.ALPHA.
Phosphonoformic acid trisodium salt hexahydrate
Phosphonoformic acid, trisodium salt
Phosphonoformic acid, trisodium salt, hexahydrate
Phosphonomethanoic acid
Prestwick_1024
SPBio_000735
SPECTRUM1502019
Sodium phosphonoformate tribasic hexahydrate
Spectrum2_000668
Spectrum3_001484
Spectrum4_000840
Spectrum5_000932
Spectrum_001359
Triapten
Trisodium carboxyphosphate
Trisodium phosphonoformate
Trisodium phosphonoformate hexahydrate
Trisodium phosphonoformte hexahydrate
UNII-364P9RVW4X
UNII-964YS0OOG1
Virudin
dihydroxyphosphanecarboxylic acid oxide
foscarnet
foscarnet sodium hexahydrate
phosphonomethanoic acid
sodium dioxidophosphanecarboxylate oxide hydrate(3:1:6)
trisodium carboxyphosphate (anhydrous)
trisodium dioxidophosphanecarboxylate oxide
trisodium dioxidophosphinecarboxylate oxide
trisodium phosphonatoformate
trisodium phosphonatoformate hexahydrate
trisodium phosphonoformate (anhydrous)
5
KetorolacapprovedPhase 432374103-06-3, 66635-83-43826
Synonyms:
(+-)-5-Benzoyl-2,3-dihydro-1H-pyrrolizine-1-carboxylic acid
(+-)-Ketorolac
(+-)-isomer
(.+/-.)-2,3-Dihydro-5-benzoyl-1H-pyrrolizine-1-carboxylic acid
1H-Pyrrolizine-1-carboxylic acid, 5-benzoyl-2,3-dihydro
5-(phenylcarbonyl)-2,3-dihydro-1H-pyrrolizine-1-carboxylic acid
5-Benzoyl-1,2-dihydro-3H-pyrrolo(1,2a)pyrrole-1-carboxylic acid
5-Benzoyl-2,3-dihydro-1H-pyrrolizine-1-carboxylic acid
66635-83-4
74103-06-3
AB00053682
AC-545
AC1L1GSW
BRD-A40639672-234-05-7
C07062
CHEBI:105080
CHEMBL469
CID3826
D020910
D08104
DB00465
 
I14-2832
Ketoralac
Ketorolac
Ketorolac (INN)
Ketorolac Tromethamine
Ketorolac [INN:BAN]
Ketorolaco
Ketorolaco [Spanish]
Ketorolacum
Ketorolacum [Latin]
Kétorolac
LS-139094
Macril
MolPort-005-933-093
NCGC00185990-01
RS 37619
RS-37619
SBB067312
STL018674
Toradol (TN)
UNII-YZI5105V0L
ketorolac
rac-Ketorolac
6
NepafenacapprovedPhase 44278281-72-8151075
Synonyms:
2-amino-3-Benzoylbenzeneacetamide
AHR 9434
AHR-9434
AL 6515
 
AL-6515
Amfenac amide
Nepafenaco
Nepafenacum
Nevanac
7
Methylprednisoloneapproved, vet_approvedPhase 4, Phase 2119383-43-26741
Synonyms:
(6S,8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-17-(2-hydroxyacetyl)-6,10,13-trimethyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-one
(6a,11b)-11,17,21-Trihydroxy-6-methylpregna-1,4-diene-3,20-dione
(6alpha,11beta)-11,17,21-Trihydroxy-6-methylpregna-1,4-diene-3,20-dione
(6α,11β)-11,17,21-trihydroxy-6-methylpregna-1,4-diene-3,20-dione
.DELTA.1-6.alpha.-Methylhydrocortisone
1-Dehydro-6alpha-methylhydrocortisone
1-dehydro-6alpha-Methylhydrocortisone
1-dehydro-6α-methylhydrocortisone
11-beta,17,21-Trihydroxy-6-alpha-methylpregna-1,4-diene-3,20-dione
11beta,17,21-Trihydroxy-6alpha-methylpregna-1,4-diene-3,20-dione
11beta,17alpha,21-Trihydroxy-6alpha-methyl-1,4-pregnadiene-3,20-dione
11beta,17alpha,21-Trihydroxy-6alpha-methylpregna-1,4-diene-3,20-dione
121673-01-6
4-08-00-03498 (Beilstein Handbook Reference)
46436_FLUKA
46436_RIEDEL
570-35-4
6 Methylprednisolone
6-Methylprednisolone
6-alpha-Methylprednisolone
6.alpha.-Methylprednisolone
6923-42-8
6alpha-Methyl-11beta,17alpha,21-trihydroxy-1,4-pregnadiene-3,20-dione
6alpha-Methyl-11beta,17alpha,21-triol-1,4-pregnadiene-3,20-dione
6alpha-Methylprednisolone
6alpha-methyl-11beta,17alpha,21-triol-1,4-pregnadiene-3,20-dione
83-43-2
AC1L1N7A
Artisone-Wyeth
Artisone-wyeth
BPBio1_000174
BRD-K35240538-001-03-1
BRN 2340300
BSPBio_000158
Besonia
Bio-0658
CHEBI:6888
CHEMBL650
CID6741
CPD000058330
D00407
D008775
DB00959
Depo-Medrol (acetate)
Dopomedrol
EINECS 201-476-4
Esametone
Firmacort
HMS1568H20
HMS2090B13
HSDB 3127
LMST02030178
LS-118498
Lemod
M0639_SIGMA
M1665
MEPRDL
MLS000028541
MLS001148159
MLS002207191
Medesone
Medixon
Medlone 21
 
Medrate
Medrol
Medrol (TN)
Medrol Adt Pak
Medrol Dosepak
Medrol adt pak
Medrol dosepak
Medrol, Solu-Medrol, Medrone, Methylprednisolone
Medrone
Mesopren
Metastab
Methyleneprednisolone
Methylprednisolon
Methylprednisolone
Methylprednisolone (JP15/USP/INN)
Methylprednisolone [USAN:INN:BAN:JAN]
Methylprednisolone, 6-alpha
Methylprednisolonum
Methylprednisolonum [INN-Latin]
Metilbetasone
Metilprednisolona
Metilprednisolona [INN-Spanish]
Metilprednisolone
Metilprednisolone [DCIT]
Metilprednisolone [Dcit]
Metipred
Metrisone
Metrocort
Metysolon
Moderin
MolPort-002-528-554
NCGC00022735-03
NCI60_001657
NSC-19987
NSC19987
Nirypan
Noretona
Predni N Tablinen
Prednol- L
Pregna-1,4-diene-3,20-dione, 11beta,17,21-trihydroxy-6alpha-methyl- (8CI)
Prestwick0_000279
Prestwick1_000279
Prestwick2_000279
Prestwick3_000279
Prestwick_622
Promacortine
Reactenol
S1733_Selleck
SAM002589984
SMR000058330
SPBio_002377
Sieropresol
Solomet
Summicort
Suprametil
U 7532
UNII-X4W7ZR7023
Urbason
Urbasone
Wyacort
ZINC03875560
delta(1)-6alpha-Methylhydrocortisone
delta(sup 1)-6-alpha-Methylhydrocortisone
methylprednisolone
methylprenisolone
8
BudesonideapprovedPhase 443251333-22-363006, 5281004
Synonyms:
(11-beta,16-alpha)-16,17-(Butylidenebis(oxy))-11,21-dihydroxypregna-1,4-diene-3,20-dione
(11beta,16alpha)-16,17-(Butylidenebis(oxy))-11,21-dihydroxypregna-1,4-diene-3,20-dione
(4aR,4bS,5S,6aS,6bS,8R,9aR,10aS,10bS)-5-hydroxy-6b-(hydroxyacetyl)-4a,6a-dimethyl-8-propyl-4a,4b,5,6,6a,6b,9a,10,10a,10b,11,12-dodecahydro-2H-naphtho[2',1':4,5]indeno[1,2-d][1,3]dioxol-2-one
(4aR,4bS,5S,6aS,6bS,9aR,10aS,10bS)-5-hydroxy-6b-(hydroxyacetyl)-4a,6a-dimethyl-8-propyl-4a,4b,5,6,6a,6b,9a,10,10a,10b,11,12-dodecahydro-2H-naphtho[2',1':4,5]indeno[1,2-d][1,3]dioxol-2-one
(R,S)-11b,16a,17,21,tetrahydroxypregna-1,4-diene-3,20-dione cyclic 16,17-acetal with buty raldehyde
(RS)-(11beta,16alpha)-16,17-[Butylidenebis(oxy)]-11,21-dihydroxypregna-1,4-diene-3,20-dione
(RS)-11beta,16alpha,17,21-Tetrahydroxypregna-1,4-diene-3,20-dione cyclic 16,17-acetal with butyraldehyde
(S)-16alpha,17-(Butylidenedioxy)-11beta,21-dihydroxypregna-1,4-diene-3,20-dione
11beta,21-dihydroxy-16alpha,17alpha-(butane-1,1-diyldioxy)pregna-1,4-diene-3,20-dione
16,17-Butylidenebis(oxy)-11,21-dihydroxypregna-1,4-diene-3,20-dione
16,17-Butylidenebis(oxy)-11-,21-dihydroxypregna-1,4-diene-3,20-dione
16-alpha,17-alpha-Butylidenedioxy-11-beta,21-dihydroxy-1,4-pregnadiene-3,20-dione
16alpha(R),17-(Butylidenebis(oxy))-11beta,21-dihydroxypregna-1,4-diene-3,20-dione
16alpha-,17alpha--butylidenedioxypregna-1,4-diene-11beta-,21-diol-3,20-dione
51333-22-3
AC-4697
AC1L1DQE
AC1L1Y6Y
AC1L22VC
AC1MHWI7
B 7777
B7777_SIGMA
BPBio1_000523
BRD-A34299591-001-03-4
BRD-A82238138-001-01-7
BSPBio_000475
BSPBio_002160
Bidien
Bio-0010
Budecort Inhaler
Budenofalk
Budeson
Budesonide (JAN/USAN/INN)
Budesonide Easyhaler
Budesonide MMX
Budesonide [USAN:INN:BAN:JAN]
Budesonido
Budesonido [INN-Spanish]
Budesonidum
Budesonidum [INN-Latin]
Budiair
Budicort
C25H34O6
CCRIS 5230
CHEBI:3207
CHEBI:656601
CHEMBL1370
CID2462
CID3033890
CID40000
CID5281004
CID63006
CPD000058337
Cortivent
D00246
DB01222
Desowen
Dexbudesonide
Dexbudesonide [INN]
DivK1c_000475
EINECS 257-139-7
EINECS 257-160-1
EINECS 257-161-7
EU-0100174
Entocort
Entocort EC
Entocort EC (TN)
Giona Easyhaler
HMS1569H17
HMS1921I22
HMS2094I13
HMS501H17
Horacort
 
IDI1_000475
Inflammide
KBio1_000475
KBio3_001660
KBioGR_001361
LS-187734
LS-7235
Lopac0_000174
MAP-0010
MLS000028507
MLS001077323
MLS002207112
Micronyl
Miflonide
MolPort-002-529-265
MolPort-003-666-332
MolPort-003-986-909
NCGC00015165-03
NCGC00021318-03
NCGC00021318-06
NCGC00089747-02
NCGC00089747-03
NCGC00089747-04
NCGC00178789-01
NINDS_000475
Noex
Preferid
Pregna-1,4-diene-3,20-dione, 16,17-butylidenebis(oxy)-11,21-dihydroxy-, (11beta,16alpha(R))-, and 16alpha,17-((S)-Butylidenebis(oxy))-11beta,21-dihydroxypregna-1,4-diene-3,20-dione
Prestwick0_000518
Prestwick1_000518
Prestwick2_000518
Prestwick3_000518
Prestwick_840
Pulmaxan
Pulmaxan turbohaler
Pulmicort
Pulmicort (TN)
Pulmicort Flexhaler
Pulmicort Nebuamp
Pulmicort Respules
Pulmicort Topinasal
Pulmicort Turbuhaler
Pulmicort turbuhaler
Respules
Rhinocort
Rhinocort Aqua
Rhinocort Turbuhaler
Rhinocort alpha
Rhinocort, Pulmicort , Entocort, Symbicort, Noex. Entocort EC, Budesonide
Rhinosol
S 1320
S-1320
S1286_Selleck
SAM002699898
SMR000058337
SPBio_000586
SPBio_002396
SPECTRUM1500813
ST51039033
Spectrum2_000623
Spectrum3_000620
Spectrum4_000821
Spectrum5_001738
Spirocort
TL8003397
Tridesilon
UDB
UNII-168L5HT37P
UNII-2HI1006KPH
UNII-Q3OKS62Q6X
Unit dose budesonide
ZINC03938751
ZINC04097286
budesonide
9
EthanolapprovedPhase 4213764-17-5702
Synonyms:
(C6-C9)Alkyl alcohol
02483_FLUKA
02851_FLUKA
02853_FLUKA
02854_FLUKA
02855_FLUKA
02856_FLUKA
02856_SIAL
02857_FLUKA
02857_SIAL
02858_FLUKA
02858_SIAL
02860_FLUKA
02865_FLUKA
02865_SIAL
02870_FLUKA
02870_SIAL
02875_FLUKA
02877_FLUKA
02878_FLUKA
02882_FLUKA
02882_SIAL
02883_FLUKA
02884_FLUKA
02890_FLUKA
02890_SIAL
02891_FLUKA
02891_SIAL
1-Hydroxyethane
100C.NPA
121182-78-3
187380_ALDRICH
187380_SIAL
24102_RIEDEL
24102_SIAL
24103_RIEDEL
24103_SIAL
24105_RIEDEL
24105_SIAL
24106_RIEDEL
24106_SIAL
24194_RIEDEL
24194_SIAL
245119_ALDRICH
245119_SIAL
270741_ALDRICH
270741_SIAL
277649_ALDRICH
277649_SIAL
2858_SIGMA
29221_FLUKA
32205_RIEDEL
32205_SIAL
32221_RIEDEL
32221_SIAL
32294_RIEDEL
32294_SIAL
34870_SIAL
34963_RIEDEL
39278_FLUKA
40210_ALDRICH
40210_RIEDEL
41322_FLUKA
458600_ALDRICH
458600_SIAL
459828_ALDRICH
459828_SIAL
459836_ALDRICH
459836_SIAL
459844_SIAL
48075_SUPELCO
493511_SIAL
493538_ALDRICH
493538_SIAL
493546_ALDRICH
493546_SIAL
64-17-5
676829_SIAL
68475-56-9
71076-86-3
71329-38-9
8000-16-6
8024-45-1
AC1L19TW
AC1Q31MM
AHD 2000
AI3-01706
ALCOHOL 5% IN D5-W
Absolute Alcohol
Absolute Ethanol
Absolute alcohol
Absolute ethanol
Absolute ethyl alcohol
Aethanol
Aethanol [German]
Aethylalkohol
Alcare Hand Degermer
Alcohol
Alcohol (USP)
Alcohol (ethyl)
Alcohol Anhydrous
Alcohol [USP]
Alcohol anhydrous
Alcohol dehydrated
Alcohol denatured
Alcohol etílico
Alcohol, Absolute
Alcohol, Dehydrated
Alcohol, Diluted
Alcohol, Grain
Alcohol, anhydrous
Alcohol, dehydrated
Alcohol, denatured
Alcohol, diluted
Alcohol, ethyl
Alcohols
Alcohols, C1-3
Alcohols, C30
Alcohols, C6-9
Alcool Ethylique
Alcool Etilico
Alcool ethylique
Alcool etilico
Alcool éthylique
Algrain
Alkohol
Alkohol [German]
Alkoholu Etylowego
Alkoholu etylowego
Aminoethanol
Anhydrol
Anhydrol PM 4085
Anhydrous alcohol
Anhydrous ethanol
Beta-Aminoethanol
Beta-Aminoethyl Alcohol
Beta-Ethanolamine
Beta-Hydroxyethylamine
C00469
C2H5OH
C2H6O
CCRIS 945
CDA 19
CDA 19-200
CHEBI:16236
CHEMBL545
CID702
Caswell No. 426
Caswell No. 430
Colamine
Cologne Spirit
Cologne spirit
Cologne spirits
 
D000431
D00068
DB00898
Dehydrated Ethanol
Dehydrated alcohol
Dehydrated ethanol
Denatured Alcohol
Denatured Alcohol Cd-10
Denatured Alcohol Cd-5
Denatured Alcohol Cd-5a
Denatured Alcohol Sd-1
Denatured Alcohol Sd-13a
Denatured Alcohol Sd-17
Denatured Alcohol Sd-23a
Denatured Alcohol Sd-28
Denatured Alcohol Sd-30
Denatured Alcohol Sd-39b
Denatured Alcohol Sd-39c
Denatured Alcohol Sd-3a
Denatured Alcohol Sd-40m
Denatured Ethanol
Denatured alcohol
Denatured ethanol
Desinfektol EL
Diluted Alcohol
Distilled spirits
E2385_SIGMA
E7023_ALDRICH
E7023_SIAL
E7148_ALDRICH
E7148_SIAL
E7517_SIGMA
EINECS 200-578-6
EINECS 270-649-4
EOH
EOX
ETA
Envision Conditioner Pdd 9020
Esumiru WK 88
EtOH
Etanolo
Etanolo [Italian]
Ethanol (9CI)
Ethanol 200 Proof
Ethanol 200 proof
Ethanol Absolute
Ethanol Absolute Bp
Ethanol Anhydrous
Ethanol Extra Pure
Ethanol Vapor
Ethanol [JAN]
Ethanol solution
Ethanol, Silent Spirit
Ethanol, undenatured
Ethanolum anhydricum
Ethicap
Ethyl Alcohol
Ethyl Alcohol & Water, 10%
Ethyl Alcohol & Water, 20%
Ethyl Alcohol & Water, 30%
Ethyl Alcohol & Water, 40%
Ethyl Alcohol & Water, 5%
Ethyl Alcohol & Water, 50%
Ethyl Alcohol & Water, 60%
Ethyl Alcohol & Water, 70%
Ethyl Alcohol & Water, 80%
Ethyl Alcohol & Water, 95%
Ethyl Alcohol & Water, 96%
Ethyl Alcohol Anhydrous
Ethyl Alcohol, Anhydrous
Ethyl Alcohol, Denatured
Ethyl Hydrate
Ethyl Hydroxide
Ethyl alc
Ethyl alcohol
Ethyl alcohol anhydrous
Ethyl alcohol in alcoholic beverages
Ethyl alcohol usp
Ethyl hydrate
Ethyl hydroxide
Ethylalcohol
Ethylalcohol [Dutch]
Ethylol
Ethylolamine
Ethyloxy Group
Etylowy alkohol
FEMA No. 2419
FEMA Number 2419
Fermentation alcohol
Glycinol
Grain alcohol
HSDB 531
HSDB 82
HYDROXYETHYL GROUP
Hinetoless
Hydroxyethane
I14-12648
IMS 99
Infinity Pure
Jaysol
Jaysol S
LS-1539
LTBB002977
Lux
Methylated Spirit Mineralised
Methylated spirit
Methylcarbinol
MolPort-001-785-844
Molasses alcohol
NCGC00091458-01
NCI-C03134
NSC 85228
NSC85228
Oxydimethylene Group
Potato alcohol
Punctilious ethyl alcohol
Pyro
QMHAIh@
Reagent Alcohol
Ru-Tuss Expectorant
SDA 3A
SDA 40-2
SDM No. 37
SY Fresh M
Sekundasprit
Silent spirit
Spirit
Spirits of wine
Spiritus vini
Spirt
Synasol
Tecsol
Tecsol C
Thanol
Thiofaco M-50
UNII-3K9958V90M
USAF EK-1597
Undenatured Ethanol
WLN: Q2
absolute alcohol
alcohol
alcohol etilico
bmse000297
etanol
ethanol
ethyl alcohol
grain alcohol
nchem.651-comp3c
nchembio.552-comp10
nchembio.94-comp20
spiritus vini
Äthanol
Äthylalkohol
éthanol
10
AdalimumabapprovedPhase 4494331731-18-116219006
Synonyms:
331731-18-1
Adalimumab
Adalimumab (USAN/INN)
Adalimumab (genetical recombination)
 
Adalimumab (genetical recombination) (JAN)
D02597
Humira
Humira (TN)
Humira Pen
Ig gamma-1 chain C region
11
Tofacitinibapproved, investigationalPhase 4, Phase 2108477600-75-2
Synonyms:
 
Tasocitinib
Tofacitinibum
12
MethotrexateapprovedPhase 4, Phase 3, Phase 215511959-05-2, 59-05-2126941
Synonyms:
4-amino-10-methylfolic acid
4-amino-N(10)-methylpteroylglutamic acid
Abitrexate
Amethopterin
Amethopterine
Antifolan
Arbitrexate
Emtexate
Folex
HDMTX
L-Amethopterin
Ledertrexate
MTX
Metatrexan
 
Methopterin
Methotextrate
Methotrate
Methotrexat
Methotrexate Sodium
Methotrexatum
Methylaminopterin
Methylaminopterinum
Metotrexato
Mexate
Méthotrexate
N-Bismethylpteroylglutamic Acid
N-[4-[[(2,4-diamino-6-pteridinyl)methyl]methylamino]benzoyl]-L-glutamic acid
Rheumatrex
Trexall
13
Pregabalinapproved, illicit, investigationalPhase 4, Phase 3, Phase 2361148553-50-85486971
Synonyms:
(3S)-3-(aminomethyl)-5-methylhexanoic acid
(R-)-3-isobutyl GABA
(S)-3-(Aminomethyl)-5-methylhexanoic acid
(S)-3-Isobutyl gaba
(S+)-3-isobutyl GABA
121GE001
148553-50-8
3-Isobutyl gaba
3-isobutyl GABA
AC-1158
AC1NUP03
AKOS005145504
C080245
C8H17NO2
CHEBI:236161
CHEMBL1059
CI 1008
CI-1008
CID5486971
 
D02716
DB00230
FT-0080911
HSDB 7530
LS-75191
Lyrica
Lyrica (TN)
MolPort-000-861-733
PD 144723
PD-144723
Pregabalin
Pregabalin (JAN/USAN/INN)
Pregabalin [USAN]
Pregablin
S-(+)-3-isobutylgaba
S1731_Selleck
SBB062901
TL8001062
TOS-BB-0910
UNII-55JG375S6M
14
leucovorinapproved, NutraceuticalPhase 4, Phase 3, Phase 2323558-05-954575, 6560146, 143
Synonyms:
(5-formyl-5,6,7,8-tetrahydropteroyl)glutamate
(6R,S)-5-Formyltetrahydrofolate
10-Formyl-7,8-dihydrofolate
10-Formyl-7,8-dihydrofolic acid
5-Formyl-5,6,7,8-tetrahydrofolate
5-Formyl-5,6,7,8-tetrahydrofolic acid
5-Formyl-5,6,7,8-tetrahydropteroyl-L-glutamic acid
5-Formyltetrahydrofolate
5-Formyltetrahydrofolic acid
5-Formyltetrahydropteroylglutamate
5-Formyltetrahydropteroylglutamic acid
5-formyltetrahydrofolic acid
Acide folinique
Calcium citrovorum factor
Calcium folinate
Citrovorum factor
Folinate
Folinic acid
Folinic acid calcium salt
 
Folinic acid calcium salt USP27
Folinic acid-SF
L(-)-5-Formyl-5,6,7,8-tetrahydrofolic acid
L-Leucovorin
L-N-[p-[[(2-Amino-5-formyl-5,6,7,8-tetrahydro-4-hydroxy-6-pteridinyl)methyl]amino]benzoyl]-Glutamic acid
L-leucovorin
Leucal
Leucovorin calcium
Leucovorin folinic acid
Leucovorinum
Leukovorin
Levoleucovorin
N-(5-formyl-5,6,7,8-tetrahydropteroyl)-L-glutamic acid
N5-Formyl-5,6,7,8-tetrahydrofolate
N5-Formyl-5,6,7,8-tetrahydrofolic acid
N5-Formyl-THF
N5-Formyltetrahydrofolate
N5-Formyltetrahydrofolic acid
Welcovorin
Wellcovorin
folinate
15
Folic Acidapproved, nutraceutical, vet_approvedPhase 4, Phase 3, Phase 2439259-30-36037
Synonyms:
(2S)-2-[[4-[(2-amino-4-oxo-1H-pteridin-6-yl)methylamino]benzoyl]amino]pentanedioic acid
01769_FLUKA
2d0k
33609-88-0
36653-55-1 (mono-potassium salt)
59-30-3
6484-89-5 (mono-hydrochloride salt)
AC-11682
AC1L1LNX
AI3-26387
AKOS000503224
ARONIS014410
Acfol (Spain)
Acide folique
Acide folique [INN-French]
Acido folico
Acido folico [INN-Spanish]
Acidum folicum
Acidum folicum [INN-Latin]
Acifolic
Antianemia factor
Apo-Folic
BIDD:ER0563
BIDD:GT0641
BIF0608
BPBio1_000654
BSPBio_000594
BSPBio_002338
C00504
C20H20N6O6
CAS-59-30-3
CCRIS 666
CHEBI:27470
CHEMBL1622
CID6037
CPD000471860
Cytofol
D00070
DB00158
DivK1c_000494
Dosfolat B activ
EINECS 200-419-0
F0043
F7876_SIAL
F7876_SIGMA
F8758_SIGMA
F8798_SIAL
F8890_SIGMA
FOL
Facid
Factor U
Folacid
Folacin
Folaemin
Folaemin [Netherlands]
Folan
Folasic (Australia)
Folate
Folbal
Folcidin
Folcidin (VAN)
Folcysteine
Foldine
Foldine [France]
Folettes
Foliamin
Folic
Folic acid
Folic acid (JP15/USP/INN)
Folic acid (TN)
Folic acid [BAN:INN:JAN]
Folic acid [INN:BAN:JAN]
Folic acid dihydrate
Folicet
Folicet (TN)
Folico
Folico (Italy)
Folina
Folina (Italy)
Folipac
Folsaeure
 
Folsan
Folsaure
Folsav
Folvite
Folvron
Glutamic acid, N-(p-(((2-amino-4-hydroxypyrimido(4,5-b)pyrazin-6-yl)methyl)amino)benzoyl)-, L
HMS1921D20
HMS2092N17
HMS501I16
HSDB 2002
IDI1_000494
InChI=1/C19H19N7O6/c20-19-25-15-14(17(30)26-19)23-11(8-22-15)7-21-10-3-1-9(2-4-10)16(29)24-12(18(31)32)5-6-13(27)28/h1-4,8,12,21H,5-7H2,(H,24,29)(H,27,28)(H,31,32)(H3,20,22,25,26,30)/t12-/m0/s
Incafolic
KBio1_000494
KBio2_001861
KBio2_004429
KBio2_006997
KBio3_001558
KBioGR_002222
KBioSS_001861
Kyselina listova
Kyselina listova [Czech]
LS-2157
Liver Lactobacillus casei factor
MLS001304016
MLS001335861
Millafol
Mission prenatal
Mittafol
MolPort-004-285-551
N-(4-(((2-Amino-1,4-dihydro-4-oxo-6-pteridinyl)methyl)amino)benzo- yl)-L-glutamic acid
N-(4-((2-Amino-1,4-dihydro-4-oxo-6-pteridinyl)methyl)amino)benzoyl)-L-glutamic acid
N-(4-{[(2-Amino-4-oxo-3,4-dihydropteridin-6-yl)methyl]amino}benzoyl)-L-glutamic acid
N-(4-{[(2-amino-4-oxo-1,4-dihydropteridin-6-yl)methyl]amino}benzoyl)-L-glutamic acid
N-(p-(((2-Amino-4-hydroxy-6-pteridinyl)methyl)amino)benzoyl)-L-glutamic acid
N-Pteroyl-L-glutamic acid
N-[(4-{[(2-Amino-4-oxo-1,4-dihydropteridin-6-yl)methyl]amino}phenyl)carbonyl]-L-glutamic acid
N-[(4-{[(2-amino-4-oxo-1,4-dihydropteridin-6-yl)methyl]amino}phenyl)carbonyl]-L-glutamic acid
N-[4-[[(2-Amino-3,4-dihydro-4-oxo-6-pteridinyl)methyl]amino]benzoyl]-L-glutamic acid
NCGC00016265-01
NCGC00142391-01
NINDS_000494
NSC 3073
Nifolin
Nifolin [Denmark]
Novofolacid
Novofolacid [Canada]
PGA
PGA (VAN)
Prestwick3_000627
Prestwick_230
PteGlu
Pteroyl-L-glutamate
Pteroyl-L-glutamic acid
Pteroyl-L-monoglutamate
Pteroyl-L-monoglutamic acid
Pteroylglutamate
Pteroylglutamic acid
Pteroylmonoglutamate
Pteroylmonoglutamic acid
SAM002264616
SDCCGMLS-0066738.P001
SMP2_000137
SMR000471860
SPBio_001357
SPECTRUM1502020
Serum Folate Level
Spectrum2_001459
Spectrum3_000749
Spectrum4_001751
Spectrum5_000602
Spectrum_001381
UNII-935E97BOY8
Usaf cb-13
Vitamin B11
Vitamin B9
Vitamin Bc
Vitamin Be
Vitamin M
bmse000299
folic acid
nchembio.108-comp10
16
Phosphonoacetic AcidexperimentalPhase 4334408-78-0546
Synonyms:
Carboxymethanephosphonate
Carboxymethanephosphonic acid
Disodium carboxymethylphosphonate
Disodium phosphonoacetate
Disodium phosphonoacetate monohydrate
Fosfonet
Fosfonet sodium
 
Fosfonoacetate
Fosfonoacetic acid
Lopac-P-6909
PAE
PPA
Phosphonacetate
Phosphonacetic acid
Phosphonoacetate
Phosphonoacetic acid
17Neurotransmitter AgentsPhase 4, Phase 3, Phase 218340
18Protective AgentsPhase 4, Phase 3, Phase 27443
19Prednisolone phosphatePhase 4, Phase 21193
20Prednisolone hemisuccinatePhase 4, Phase 21193
21Prednisolone acetatePhase 4, Phase 21193
22AcyclovirPhase 4, Phase 3, Phase 2, Phase 1183
23Antimetabolites, AntineoplasticPhase 4, Phase 3, Phase 27361
24Cyclooxygenase 2 InhibitorsPhase 4624
25Dermatologic AgentsPhase 4, Phase 3, Phase 25806
26valacyclovirPhase 4, Phase 3, Phase 2, Phase 1106
27Immunosuppressive AgentsPhase 4, Phase 3, Phase 2, Phase 113086
28AntipruriticsPhase 4, Phase 3, Phase 2841
29Calcium, DietaryPhase 4, Phase 3, Phase 2, Phase 15713
30AntimetabolitesPhase 4, Phase 3, Phase 212054
31Central Nervous System DepressantsPhase 4, Phase 3, Phase 2, Phase 113403
32AntiemeticsPhase 4, Phase 2, Phase 14022
33Peripheral Nervous System AgentsPhase 4, Phase 3, Phase 2, Phase 123689
34Anti-Inflammatory AgentsPhase 4, Phase 3, Phase 2, Phase 110729
35Anti-Inflammatory Agents, Non-SteroidalPhase 4, Phase 14443
36Antirheumatic AgentsPhase 4, Phase 3, Phase 2, Phase 110956
37Antineoplastic Agents, HormonalPhase 4, Phase 3, Phase 2, Phase 15592
38AnalgesicsPhase 4, Phase 3, Phase 2, Phase 111733
39VaccinesPhase 4, Phase 2, Phase 3, Phase 16611
40Anti-Retroviral AgentsPhase 4, Phase 3, Phase 2, Phase 13296
41Anti-Infective AgentsPhase 4, Phase 3, Phase 2, Phase 122062
42Antiviral AgentsPhase 4, Phase 3, Phase 2, Phase 19967
43Nucleic Acid Synthesis InhibitorsPhase 4, Phase 3, Phase 24962
44Reverse Transcriptase InhibitorsPhase 4, Phase 3, Phase 21913
45Autonomic AgentsPhase 4, Phase 3, Phase 2, Phase 110150
46Analgesics, Non-NarcoticPhase 4, Phase 2, Phase 3, Phase 16501
47Ketorolac TromethaminePhase 4323
48glucocorticoidsPhase 4, Phase 3, Phase 2, Phase 15103
49HormonesPhase 4, Phase 3, Phase 2, Phase 114415
50Cyclooxygenase InhibitorsPhase 4, Phase 12870

Interventional clinical trials:

(show top 50)    (show all 444)
idNameStatusNCT IDPhase
1Efficacy and Safety of Foscarnet Sodium and Sodium Chloride Injection in Patients With Herpes ZosterUnknown statusNCT02151240Phase 4
2Study on Effectiveness of 2-dose Live Attenuated Varicella VaccineUnknown statusNCT02146469Phase 4
3The Safety and Immunogenicity Research of Live Attenuated Varicella Vaccine After the 2 Doses VaccinationUnknown statusNCT01866566Phase 4
4Safety and Immunogenicity of Zostavax Vaccine in Patients Undergoing Living Donor Kidney TransplantationUnknown statusNCT00940940Phase 4
5Effect of Anti-inflammatory Topical Prednisolone, Nepafenac and Ketorolac in Intra-operative Mydriasis in FacetectomiesUnknown statusNCT00865540Phase 4
6Evaluation of the Efficacy, Tolerability and Safety of Etoricoxib (Arcoxia) in Patients With Neuropathic PainUnknown statusNCT01264237Phase 4
7Qutenza for Critical Ischaemia in End Stage Renal FailureUnknown statusNCT01704339Phase 4
8Olive Oil's Cream Effectiveness in Prevention of Pressure Ulcers in Immobilized Patients in Primary CareUnknown statusNCT01595347Phase 4
9T Cell Responses to Varicella Zoster Virus (VZV) Vaccine SLVP020CompletedNCT01911065Phase 4
10Immunogenicity and Safety of 2 Doses of Live Attenuated Varicella VaccineCompletedNCT02173899Phase 4
11Safety of a Second Dose of Biken's Varicella VaccineCompletedNCT00830648Phase 4
12A Study of Vacyless® Versus Valtrex® in Patients With Herpes ZosterCompletedNCT02152800Phase 4
13ZOSTAVAX™ Safety and Immunogenicity in Korean Adults (V211-034)CompletedNCT01556451Phase 4
14Safety and Immunogenicity Study of Live Attenuated Vaccine Against Varicella Without GelatinCompletedNCT01684072Phase 4
15Immunogenicity and Safety Study of 2 Doses of Live Attenuated Varicella VaccineCompletedNCT01817270Phase 4
16Immunogenicity and Safety of Live Attenuated Varicella Vaccine Combined With Live Attenuated JE VaccineCompletedNCT01815073Phase 4
17Varicella Vaccination With PulmicortCompletedNCT00641446Phase 4
18The Immunogenicity of Varicella-zoster Virus Vaccine in HIV-infected ChildrenCompletedNCT01138215Phase 4
19ZOSTAVAX™ Safety Study in Subjects ≥ 60 Years of Age (V211-020)CompletedNCT00550745Phase 4
20Placebo Controlled Evaluation of the Cell Mediated Immune Response of Cirrhotic Subjects to Zostavax™CompletedNCT02958345Phase 4
21Zostavax® at Minimum Release Specification Approaching ExpiryCompletedNCT00681031Phase 4
22Effective Study of Live Attenuated Varicella Vaccine to Treat Severe Resistant PsoriasisCompletedNCT01356004Phase 4
23MMR and Varicella Vaccine in Premature InfantsCompletedNCT00156559Phase 4
24Concomitant Use of Hepatitis A Vaccine With Measles, Mumps, Rubella and Varicella Vaccine and Pneumococcal 7-Valent Conjugate Vaccine in Healthy 12-Month-Old Children (V251-067)CompletedNCT00312858Phase 4
25Immunogenicity and Safety of Combined Vaccine to Prevent Measles, Mumps, Rubella and Chickenpox DiseasesCompletedNCT00126997Phase 4
26Hepatitis A Vaccine, Inactivated and Measles, Mumps, Rubella and Varicella Virus Vaccine Live Safety Study (V251-066)(COMPLETED)CompletedNCT00326183Phase 4
27Effectiveness Assessment of Vaccinating Schoolchildren Against InfluenzaCompletedNCT01693380Phase 4
28Palatability Testing of a New Paediatric Formulation of ValacyclovirCompletedNCT01682109Phase 4
29Safety Study of a Refrigerator-stable Formulation of VARIVAX®CompletedNCT00432731Phase 4
30An Efficacy And Safety Study Evaluating Tofacitinib With And Without Methotrexate Compared To Adalimumab With MethotrexateCompletedNCT02187055Phase 4
31MF59-adjuvanted Influenza Vaccine and 23-valent Pneumococcal Polysaccharide VaccineCompletedNCT02225327Phase 4
32Pregabalin in the Treatment of Essential TremorCompletedNCT00646451Phase 4
33Immunogenicity and Safety of PCV13 and Fluad in Adults Aged ≥60 YearsCompletedNCT02215863Phase 4
34Study of the Influence of Vaccination in HIV Viral Load and Immunologic Responses Against HIVCompletedNCT00329251Phase 4
35Comparison of Slow and Fast Transition From Stimulants to Atomoxetine in Children and Adolescents With Attention Deficit/Hyperactivity Disorder(ADHD)CompletedNCT00760747Phase 4
36Safety and Tolerability of Herpes Zoster Vaccine Rheumatologic PatientsRecruitingNCT03016884Phase 4
37Acupuncture in Herpes Zoster Neuralgia (ACUZoster)RecruitingNCT00885586Phase 4
38Immune Response to Shingles VaccinationRecruitingNCT02624375Phase 4
39Safety and Immunogenicity of a Zoster Vaccine in SLERecruitingNCT02477150Phase 4
40"Equistasi" and Gait in HemiparesisRecruitingNCT02714478Phase 4
41Pilot Study to Describe Immune Responses of Healthy Women Following Immunization With Varicella Zoster Virus VaccineActive, not recruitingNCT02514018Phase 4
42Immune Persistence After Inoculated With One-dose Freeze-Dried Live Attenuated Varicella Vaccine in Children Vaccine in ChildrenActive, not recruitingNCT01982409Phase 4
43The Safety, Immunogenicity and Immune Effect Research of the Varicella Vaccine After the 2nd Dose VaccinationEnrolling by invitationNCT01830283Phase 4
44Immunodeficiency in Cartilage-hair Hypoplasia: Sub-project on Safety of Vaccination Against ChickenpoxEnrolling by invitationNCT02383797Phase 4
45Persistence of Varicella Immunity in Hospital Employees Receiving Varicella VaccineNot yet recruitingNCT02026089Phase 4
46Zoster Eye Disease StudyNot yet recruitingNCT03134196Phase 4
47ZOSTAVAX in Persons Imminently Receiving Chemotherapy for Solid Organ TumorsNot yet recruitingNCT02444936Phase 4
48Varicella Zoster Vaccine in Patients With Plaque Psoriasis Treated With Biologic TherapyTerminatedNCT02408159Phase 4
49Responses of Premature Infants to Measles-Mumps-Rubella (MMR) and Varicella VaccinesTerminatedNCT00138255Phase 4
50Serological Evaluation of Varicella and Hepatitis A Vaccines Using Injector DeliveryUnknown statusNCT00926419Phase 2, Phase 3

Search NIH Clinical Center for Herpes Zoster

Inferred drug relations via UMLS68/NDF-RT46:


Cochrane evidence based reviews: herpes zoster

Genetic Tests for Herpes Zoster

About this section

Anatomical Context for Herpes Zoster

About this section

MalaCards organs/tissues related to Herpes Zoster:

36
Skin, Eye, Kidney, T cells, Colon, Testes, Bone

FMA organs/tissues related to Herpes Zoster:

17
Nerve fiber

Publications for Herpes Zoster

About this section

Articles related to Herpes Zoster:

(show top 50)    (show all 1230)
idTitleAuthorsYear
1
Successful Treatment of Brachial Plexopathy Due to Herpes Zoster Infection With Intravenous Immunoglobulin. (27879550)
2017
2
Cost of shingles: population based burden of disease analysis of herpes zoster and postherpetic neuralgia. (28086817)
2017
3
Gentiana scabra Bunge. Formula for Herpes Zoster: Biological Actions of Key Herbs and Systematic Review of Efficacy and Safety. (28078812)
2017
4
Improvement in Herpes Zoster Vaccination in Patients with Rheumatoid Arthritis: A Quality Improvement Project. (28042124)
2017
5
Localized hypohidrosis is an unrecognized sequela of herpes zoster. (27986141)
2017
6
Association of cigarette smoking with a past history and incidence of herpes zoster in the general Japanese population: the SHEZ Study. (28091339)
2017
7
Immunogenicity and safety of an adjuvanted herpes zoster subunit candidate vaccine in adults a8Y50A years of age with a prior history of herpes zoster: a phase III, non-randomized, open-label clinical trial. (28068212)
2017
8
Risk and severity of herpes zoster in patients with rheumatoid arthritis receiving different immunosuppressive medications: a case-control study in Asia. (28057661)
2017
9
Clinical characteristics of headache or facial pain prior to the development of acute herpes zoster of the head. (27978460)
2017
10
Three cases of herpes zoster radiculitis in MS patients treated with natalizumab. (27645358)
2016
11
A Rare Patient With Orbital Apex Syndrome, Anterior Uveitis, and Necrotizing Scleritis Due to Herpes Zoster Ophthalmicus. (28005810)
2016
12
Herpes zoster in children. (27622252)
2016
13
Acute Orbital Syndrome in Herpes Zoster Ophthalmicus: Clinical Features of 7 Cases. (27046033)
2016
14
Concurrent hyphema and orbital apex syndrome following herpes zoster ophthalmicus in a middle aged lady. (28061417)
2016
15
Shingles (Herpes Zoster) Vaccine (Zostavax(Ar)): A Review in the Prevention of Herpes Zoster and Postherpetic Neuralgia. (27189459)
2016
16
Atypical pityriasis rosea presenting with a herald patch lesion on the healed site of herpes zoster: Wolf's isotopic response. (26678150)
2016
17
Efficacy of the Herpes Zoster Subunit Vaccine in Adults 70 Years of Age or Older. (27626517)
2016
18
Herpes Zoster Ophthalmicus: A Review for the Internist. (27644149)
2016
19
Comorbidities: Stroke risk increased after herpes zoster infection. (27652501)
2016
20
Prevention: Time to re-evaluate herpes zoster vaccination? (27052483)
2016
21
Effect of Repetitive Intracutaneous Injections with Local Anesthetics and Steroids for Acute Thoracic Herpes Zoster and Incidence of Postherpetic Neuralgia. (27492741)
2016
22
Herpes zoster reactivation after extracorporeal shock wave lithotripsy: A case report. (27555686)
2016
23
Update on Incidence of Herpes Zoster Among Children and Adolescents After Implementation of Varicella Vaccination, Antelope Valley, CA, 2000 to 2010. (27622686)
2016
24
Risk of Herpes Zoster and Family History: A Meta-analysis of Case-control Studies. (27057014)
2016
25
Assessment of the Accuracy of Using ICD-9 Codes to Identify Uveitis, Herpes Zoster Ophthalmicus, Scleritis, and Episcleritis. (27387135)
2016
26
A rare case report and appraisal of the literature on spontaneous tooth exfoliation associated with trigeminal herpes zoster. (27154513)
2016
27
Herpes Zoster Meningitis Complicating Combined Tocilizumab and Cyclosporine Therapy for Adult-Onset Still's Disease. (27092286)
2016
28
Favorable Long-term Prognosis of Cataract Surgery in Herpes Zoster Ophthalmicus. (27413505)
2016
29
Incidence of serum antibody titers against varicella zoster virus in Japanese patients with herpes zoster. (28012212)
2016
30
Valacyclovir versus acyclovir for the treatment of herpes zoster ophthalmicus in immunocompetent patients. (27841441)
2016
31
Herpes Zoster Masquerading as a Chemical Burn Secondary to Hair Dye. (27606555)
2016
32
European consensus-based (S2k) Guideline on the Management of Herpes Zoster - guided by the European Dermatology Forum (EDF) in cooperation with the European Academy of Dermatology and Venereology (EADV), Part 2: Treatment. (27579792)
2016
33
Corneal Reinnervation and Sensation Recovery in Patients With Herpes Zoster Ophthalmicus: An In Vivo and Ex Vivo Study of Corneal Nerves. (26989956)
2016
34
Transient Receptor Potential Vanilloid-1 in Epidermal Keratinocytes May Contribute to Acute Pain in Herpes Zoster. (26390894)
2016
35
Herpes zoster occurring on scars: two cases. (27086602)
2016
36
Disease Burden Due to Herpes Zoster among Population Aged a8Y50 Years Old in China: A Community Based Retrospective Survey. (27055179)
2016
37
Herpes Zoster and the Risk for Stroke in Patients with Autoimmune Diseases. (27588578)
2016
38
A case of miller fisher syndrome associated with preceding herpes zoster ophthalmicus. (27875624)
2016
39
Association of Herpes Zoster and Type 1 Diabetes Mellitus. (27171477)
2016
40
Orbital myositis: A rare complication of ophthalmic herpes zoster. (27595510)
2016
41
Herpes Zoster Meningitis Presenting With a Cerebrospinal Fluid Leukemoid Reaction in an Adolescent With preB-ALL in Remission. (27322719)
2016
42
Post Herpes Zoster Trigeminal Trophic Syndrome in a Child: An Example of Immunocompromised District. (26955150)
2016
43
Case of thymoma-associated multi-organ autoimmunity following herpes zoster. (27943470)
2016
44
COST-EFFECTIVENESS ANALYSIS OF HERPES ZOSTER VACCINATION IN ITALIAN ELDERLY PERSONS. (27624398)
2016
45
The Epidemiology of Herpes Zoster After Varicella Immunization Under Different Biological Hypotheses: Perspectives From Mathematical Modeling. (26994062)
2016
46
Post-Herpes zoster myelitis in a very old patient: A complication not to be missed. (27440114)
2016
47
Prevalence of Ocular Manifestations and Visual Outcomes in Patients With Herpes Zoster Ophthalmicus. (27741018)
2016
48
Benefit and Risk of Tofacitinib in the Treatment of Rheumatoid Arthritis: A Focus on Herpes Zoster. (27193610)
2016
49
Herpes Zoster as the Presenting Manifestation of Systemic Lupus Erythematosus (SLE): A Rare Case Report. (27134921)
2016
50
Increasing Incidence of Herpes Zoster Over a 60-year Period From a Population-based Study. (27161774)
2016

Variations for Herpes Zoster

About this section

Expression for genes affiliated with Herpes Zoster

About this section
Search GEO for disease gene expression data for Herpes Zoster.

Pathways for genes affiliated with Herpes Zoster

About this section

Pathways related to Herpes Zoster according to GeneCards Suite gene sharing:

(show all 28)
idSuper pathwaysScoreTop Affiliating Genes
19.3CD40LG, IFNG, IL2
2
Show member pathways
9.3CD40LG, IFNG, IL2
3
Show member pathways
9.3CD40LG, IFNG, IL2
49.2IFNG, IL10, IL2
5
Show member pathways
9.2IFNG, IL10, IL2
69.2IFNG, IL10, IL2
79.2IFNG, IL10, IL2
8
Show member pathways
9.2IFNG, IL10, IL2
99.0CD40LG, FCGR3A, IL10
109.0CD40LG, IFNG, IL10
118.9FCGR3A, IFNA2, IFNG, IL10
12
Show member pathways
8.8IFNA2, IFNG, IL10, IL2
138.8IFNA2, IFNG, IL10, IL2
14
Show member pathways
8.7CD40LG, FCGR3A, IFNG, IL10
15
Show member pathways
8.7FCGR3A, HLA-A, IFNA2, IFNG, IL2
168.7CD40LG, CD8A, HLA-A
17
Show member pathways
8.7CD40LG, IFNG, IL10, IL2
18
Show member pathways
8.5CD8A, HLA-A, IFNG, IL2
19
Show member pathways
8.5CD8A, HLA-A, IFNG, IL2
208.4CD40LG, CD8A, FCGR3A, HLA-A
218.4CD8A, IFNG, IL10, IL2
22
Show member pathways
8.4HLA-A, IFNA2, IFNG, IL10, IL2
238.0CD8A, IFNA2, IFNG, IL10, IL2
248.0CD8A, IFNA2, IFNG, IL10, IL2
257.8CD40LG, CD8A, IFNG, IL10, IL2
26
Show member pathways
7.8CD40LG, CD8A, IFNG, IL10, IL2
27
Show member pathways
7.8CD40LG, HLA-A, IFNA2, IFNG, IL10, IL2
28
Show member pathways
7.0CD40LG, CD8A, HLA-A, IFNA2, IFNG, IL10

GO Terms for genes affiliated with Herpes Zoster

About this section

Cellular components related to Herpes Zoster according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1external side of plasma membraneGO:00098978.3CD40LG, CD8A, FCGR3A, IFNG, TRPV1

Biological processes related to Herpes Zoster according to GeneCards Suite gene sharing:

(show all 16)
idNameGO IDScoreTop Affiliating Genes
1positive regulation of isotype switching to IgG isotypesGO:004830410.4IFNG, IL2
2positive regulation of peptidyl-serine phosphorylation of STAT proteinGO:003314110.4IFNA2, IFNG
3positive regulation of interleukin-12 productionGO:003273510.3CD40LG, IFNG
4defense response to protozoanGO:004283210.2IFNG, IL10
5negative regulation of growth of symbiont in hostGO:004413010.2IFNG, IL10
6positive regulation of MHC class II biosynthetic processGO:004534810.2IFNG, IL10
7positive regulation of tyrosine phosphorylation of STAT proteinGO:004253110.0IFNA2, IFNG, IL2
8positive regulation of T cell proliferationGO:00421029.9CD40LG, IFNG, IL2
9sensory perception of mechanical stimulusGO:00509549.9IFNG, TRPV1
10B cell differentiationGO:00301839.7CD40LG, IFNA2, IL10
11B cell proliferationGO:00421009.7CD40LG, IFNA2, IL10
12antigen processing and presentationGO:00198829.6CD8A, HLA-A, IFNG
13cell surface receptor signaling pathwayGO:00071669.4CD8A, IFNA2, IFNG, TRPV1
14inflammatory responseGO:00069549.3CD40LG, IFNA2, IL10, TRPV1
15immune responseGO:00069557.8CD40LG, CD8A, FCGR3A, HLA-A, IFNG, IL10
16regulation of immune responseGO:00507767.7CD40LG, CD8A, COL17A1, FCGR3A, HLA-A, IFNG

Molecular functions related to Herpes Zoster according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1cytokine activityGO:00051258.3CD40LG, IFNA2, IFNG, IL10, IL2

Sources for Herpes Zoster

About this section
2CDC
6CNVD
10DGIdb
15ExPASy
16FDA
17FMA
27GTR
28HGMD
29HMDB
30ICD10
31ICD10 via Orphanet
32ICD9CM
33IUPHAR
34KEGG
37MedGen
39MeSH
40MESH via Orphanet
41MGI
44NCI
45NCIt
46NDF-RT
49NINDS
50Novoseek
52OMIM
53OMIM via Orphanet
57PubMed
58QIAGEN
63SNOMED-CT via Orphanet
67Tumor Gene Family of Databases
68UMLS
69UMLS via Orphanet